Lothar Kanz

36.9k total citations · 2 hit papers
579 papers, 22.1k citations indexed

About

Lothar Kanz is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Lothar Kanz has authored 579 papers receiving a total of 22.1k indexed citations (citations by other indexed papers that have themselves been cited), including 235 papers in Hematology, 196 papers in Oncology and 154 papers in Immunology. Recurrent topics in Lothar Kanz's work include Hematopoietic Stem Cell Transplantation (114 papers), Acute Myeloid Leukemia Research (66 papers) and Immune Cell Function and Interaction (66 papers). Lothar Kanz is often cited by papers focused on Hematopoietic Stem Cell Transplantation (114 papers), Acute Myeloid Leukemia Research (66 papers) and Immune Cell Function and Interaction (66 papers). Lothar Kanz collaborates with scholars based in Germany, United States and Switzerland. Lothar Kanz's co-authors include Wolfram Brugger, Carsten Bokemeyer, Robert Möhle, Peter Brossart, Christian Kollmannsberger, Hans‐Jörg Bühring, Frank Bautz, Roland Mertelsmann, Wichard Vogel and Hans‐Georg Rammensee and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Lothar Kanz

563 papers receiving 21.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Infusion of cytomegalovirus (CMV)–specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy

2002 559 citations Jürgen Löffler, Hans‐Georg Rammensee et al. Blood profile →
The Chemokine Receptor CXCR-4 Is Expressed on CD34+Hematopoietic Progenitors and Leukemic Cells and Mediates Transendothelial Migration Induced by Stromal Cell-Derived Factor-1

1998 536 citations Robert Möhle, Wolfram Brugger et al. Blood profile →

Peers

Countries citing papers authored by Lothar Kanz

Since Specialization

Citations

This map shows the geographic impact of Lothar Kanz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lothar Kanz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lothar Kanz more than expected).

Fields of papers citing papers by Lothar Kanz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lothar Kanz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lothar Kanz. The network helps show where Lothar Kanz may publish in the future.

Co-authorship network of co-authors of Lothar Kanz

This figure shows the co-authorship network connecting the top 25 collaborators of Lothar Kanz. A scholar is included among the top collaborators of Lothar Kanz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lothar Kanz. Lothar Kanz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Low Graft Invariant Natural Killer T-Cell Dose Is a Risk Factor for Cytomegalovirus Reactivation After Allogeneic Hematopoietic Cell Transplantation 2022 ·Transplantation and Cellular Therapy ·Dominik Schneidawind, (unknown), (unknown), Susanne S. Renner, (unknown), Daniel Atar, Hildegard Keppeler, Robert Beck, Klaus Hamprecht, Lothar Kanz, Claudia Lengerke, Corina Schneidawind	4
2	G‐CSF administration prior to donor lymphocyte apheresis promotes anti‐leukaemic effects in allogeneic HCT patients 2019 ·British Journal of Haematology ·Corina Schneidawind, (unknown), (unknown), Michael Schumm, Rupert Handgretinger, Christoph Faul, Lothar Kanz, Wolfgang Bethge, Dominik Schneidawind	20
3	Mapping the HLA Ligandome of Colorectal Cancer Reveals an Imprint of Malignant Cell Transformation 2018 ·Cancer Research ·Markus Löffler, Daniel J. Kowalewski, Linus Backert, Jörg Bernhardt, Patrick Adam, Heiko Schuster, (unknown), (unknown), Hans‐Georg Kopp, Stefan Beckert, Silvia Wagner, Ingmar Königsrainer, Oliver Kohlbacher, Lothar Kanz, Alfred Königsrainer, Hans‐Georg Rammensee, Stefan Stevanović, Sebastian P. Haen	36
4	Definition and Characterization of a Peptide Warehouse for the Patient-Individualized Peptide Vaccination Study (iVAC-L-CLL01) after First Line Therapy of CLL 2017 ·Blood ·Tatjana Bilich, Annika Nelde, Daniel J. Kowalewski, Lothar Kanz, Hans‐Georg Rammensee, Stefan Stevanović, Helmut R. Salih, Juliane S. Walz	2
5	Platelet Programmed Cell Death Ligand 1 (pPDL-1) Is a Prognostic Marker in Advanced Lung Cancer 2017 ·Blood ·Clemens Hinterleitner, (unknown), Stefan Wirths, Stefanie Bugl, Elke Malenke, (unknown), Lothar Kanz, Hans‐Georg Kopp	1
6	Follow‐up of patients with refractory or relapsed multiple myeloma after allogeneic hematopoietic cell transplantation 2017 ·Clinical Transplantation ·Corina Schneidawind, (unknown), Christoph Faul, Lothar Kanz, Katja Weisel, Wolfgang Bethge, Dominik Schneidawind	6
7	BAALC Is a Key Mediator of Leukemia Development in Congenital Neutropenia 2017 ·Blood ·Benjamin Dannenmann, Maksim Klimiankou, (unknown), (unknown), (unknown), (unknown), (unknown), Christian Lindner, Tatsuya Morishima, Doris Steinemann, Cornelia Zeidler, Lothar Kanz, Karl Welte, Julia Skokowa	1
8	Addition of Plerixafor Overcomes Poor Mobilization in Autologous and Allogeneic Stem Cell Grafts and Leads to Efficient and Sustained Engraftment 2017 ·Blood ·Sebastian P. Haen, (unknown), Michael Schumm, Jörg Henes, Robert Möhle, Wolfgang Bethge, Lothar Kanz, Wichard Vogel	1
9	Prominent Oncogenic Roles of EVI1 in Breast Carcinoma 2017 ·Cancer Research ·Hui Wang, Thorsten Schaefer, Martina Konantz, Martin Braun, Zsuzsanna Varga, Anna Paczulla, Selina Reich, Francis Jacob, Sven Perner, Holger Moch, Tanja Fehm, Lothar Kanz, Klaus Schulze‐Osthoff, Claudia Lengerke	31
10	SOX2 Expression Associates with Stem Cell State in Human Ovarian Carcinoma 2013 ·Cancer Research ·Petra M. Bareiss, Anna Paczulla, Hui Wang, Rebekka Schairer, Stefan Wiehr, Ursula Kohlhofer, Oliver C. Rothfuss, Anna Fischer, Sven Perner, Annette Staebler, D. Wallwiener, Falko Fend, Tanja Fehm, Bernd J. Pichler, Lothar Kanz, Leticia Quintanilla-Martı́nez, Klaus Schulze‐Osthoff, Frank Eßmann, Claudia Lengerke	126
11	SOX2 Expression and Prognostic Significance in Ovarian Carcinoma 2013 ·International Journal of Gynecological Pathology ·(unknown), Veit Scheble, Petra M. Bareiss, Anna Fischer, (unknown), A. Adam, Cornelia Bachmann, Hans Neubauer, Hans Bösmüller, Lothar Kanz, D. Wallwiener, Falko Fend, Claudia Lengerke, Sven Perner, Tanja Fehm, Annette Staebler	32
12	Steady-state neutrophil homeostasis is dependent on TLR4/TRIF signaling 2012 ·Blood ·Stefanie Bugl, Stefan Wirths, Markus P. Radsak, Hansjörg Schild, Pamela Stein, Maya C. André, Martin Müller, Elke Malenke, Tina Wiesner, Melanie Märklin, Julia-Stefanie Frick, Rupert Handgretinger, Hans‐Georg Rammensee, Lothar Kanz, Hans‐Georg Kopp	78
13	Cyclophosphamide for large vessel vasculitis: assessment of response by PET/CT. 2011 ·PubMed ·J. Henes, Mark Mueller, Christina Pfannenberg, Lothar Kanz, Ina Kötter	54
14	R-CHOP VERSUS R-FC FOLLOWED BY MAINTENANCE WITH RITUXIMAB OR IFN: FIRST RESULTS OF A RANDOMIZED TRIAL FOR ELDERLY PATIENTS WITH MANTLE CELL LYMPHOMA 2011 ·Annals of Oncology ·Hanneke C. Kluin‐Nelemans, Eva Hoster, Olivier Hermine, Jan Walewski, Marek Trněný, Carsten Geisler, W. Klapper, Ursula Vehling‐Kaiser, Michał Szymczyk, C Gisselbrecht, S. Stilgenbauer, Bertrand Coiffier, Lothar Kanz, Jeanette K. Doorduijn, (unknown), Martin Dreyling	4
15	Immunologic and Clinical Responses after Vaccinations with Peptide-Pulsed Dendritic Cells in Metastatic Renal Cancer Patients 2006 ·Cancer Research ·Jan Wierecky, Martin Müller, Stefan Wirths, (unknown), Daniela Dörfel, Susanne M. Schmidt, Maik Häntschel, Wolfram Brugger, Stephen Schröder, Marius Horger, Lothar Kanz, Peter Brossart	185
16	Ex Vivo Expansion of Normal Progenitor Cells from Acute Myeloid Leukemia Cell-Contaminated CD34 ⁺ Peripheral Blood Progenitor Cells after Mafosfamide Purging 2001 ·Journal of Hematotherapy & Stem Cell Research ·(unknown), Frank Grünebach, Peter Bader, Wichard Vogel, Lothar Kanz, Wolfram Brugger, Stefan Scheding	1
17	Molecular methods in the diagnosis of infections in the immunocompromised host 2000 ·Current Opinion in Infectious Diseases ·Holger Hebart, Juergen Loeffler, Lothar Kanz, Hermann Einsele	3
18	Hematopoietic stem cells : biology and transplantation 1999 ·New York Academy of Sciences eBooks ·Donald Orlic, Thomas Böck, Lothar Kanz	2
19	Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer 1998 ·British Journal of Cancer ·Carsten Bokemeyer, C. Berger, (unknown), Christian Kollmannsberger, Hans‐Joachim Schmoll, M. Kuczyk, Lothar Kanz	248
20	New Aspects for the Diagnosis of Invasive Fungal Disease in Oncological Patients 1997 ·Oncology Research and Treatment ·Holger Hebart, C. Bokemeyer, Jürgen Löffler, Ulrike Schumacher, Lothar Kanz, H. Einsele	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact